Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Reslizumab for the Treatment of Chronic Rhinosinusitis A Double Blind, Randomized, Placebo-controlled, Phase III Trial

NCT02799446 is registered in ClinicalTrials.gov with Joshua S. Jacobs as lead sponsor.

NCT NCT02799446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02799446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Reslizumab for the Treatment of Chronic Rhinosinusitis A Double Blind, Randomized, Placebo-controlled, Phase III Trial
Lead sponsor
Joshua S. Jacobs
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2016
Completion date
July 31, 2019
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sinusitis